Suppr超能文献

特发性肺纤维化中的淋巴管:对一种古老疾病的新见解。

Lymphatics in idiopathic pulmonary fibrosis: new insights into an old disease.

作者信息

El-Chemaly Souheil, Pacheco-Rodriguez Gustavo, Ikeda Yoshihiko, Malide Daniela, Moss Joel

机构信息

Translational Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892-1590, USA.

出版信息

Lymphat Res Biol. 2009 Dec;7(4):197-203. doi: 10.1089/lrb.2009.0014.

Abstract

The lymphatic vasculature plays a key role in tissue homeostasis and immune surveillance. There is mounting evidence of a role for the lymphatic circulation and for newly formed lymphatic vessels in the pathogenesis of lung disease. Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, debilitating lung disease. In IPF, the lung parenchyma undergoes extensive remodeling. This review focuses on the current knowledge and understanding of the pathogenesis of IPF, and recent evidence of the involvement of lymphangiogenesis in lung injury and repair and the molecular and cellular pathways leading to the development of lymphatic vasculature.

摘要

淋巴脉管系统在组织稳态和免疫监视中起关键作用。越来越多的证据表明,淋巴循环和新形成的淋巴管在肺部疾病的发病机制中发挥作用。特发性肺纤维化(IPF)是一种慢性、进行性、使人衰弱的肺部疾病。在IPF中,肺实质会发生广泛的重塑。本综述聚焦于目前对IPF发病机制的认识和理解,以及淋巴管生成参与肺损伤和修复的最新证据,以及导致淋巴脉管系统发育的分子和细胞途径。

相似文献

1
Lymphatics in idiopathic pulmonary fibrosis: new insights into an old disease.
Lymphat Res Biol. 2009 Dec;7(4):197-203. doi: 10.1089/lrb.2009.0014.
2
Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms.
Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3958-63. doi: 10.1073/pnas.0813368106. Epub 2009 Feb 23.
3
Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis.
Eur Respir Rev. 2012 Sep 1;21(125):196-206. doi: 10.1183/09059180.00009311.
4
The Lymphatic Highway: How Lymphatics Drive Lung Health and Disease.
Lung. 2024 Oct;202(5):487-499. doi: 10.1007/s00408-024-00739-6. Epub 2024 Aug 20.
5
The disappearance of subpleural and interlobular lymphatics in idiopathic pulmonary fibrosis.
Lymphat Res Biol. 2010 Dec;8(4):199-207. doi: 10.1089/lrb.2010.0008.
6
New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis.
Drugs. 2011 May 28;71(8):981-1001. doi: 10.2165/11591490-000000000-00000.
7
Stem Cell and Idiopathic Pulmonary Fibrosis: Mechanisms and Treatment.
Curr Stem Cell Res Ther. 2015;10(6):466-76. doi: 10.2174/1574888x10666150519092639.
8
Pathognomonic remodeling of blood and lymphatic capillaries in idiopathic pulmonary fibrosis.
Respir Investig. 2017 Jan;55(1):2-9. doi: 10.1016/j.resinv.2016.08.005. Epub 2016 Oct 22.
9
Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer.
Chest. 2019 Aug;156(2):383-391. doi: 10.1016/j.chest.2019.04.114. Epub 2019 May 22.
10
New therapeutics based on emerging concepts in pulmonary fibrosis.
Expert Opin Ther Targets. 2019 Jan;23(1):69-81. doi: 10.1080/14728222.2019.1552262. Epub 2018 Nov 28.

引用本文的文献

1
The Lymphatic Highway: How Lymphatics Drive Lung Health and Disease.
Lung. 2024 Oct;202(5):487-499. doi: 10.1007/s00408-024-00739-6. Epub 2024 Aug 20.
3
Acute Respiratory Distress Syndrome: Focus on Viral Origin and Role of Pulmonary Lymphatics.
Biomedicines. 2021 Nov 20;9(11):1732. doi: 10.3390/biomedicines9111732.
4
The pathogenesis and pathology of idiopathic pleuroparenchymal fibroelastosis.
Histol Histopathol. 2021 Mar;36(3):291-303. doi: 10.14670/HH-18-289. Epub 2020 Dec 14.
5
Role of alveolar collapse in idiopathic pleuroparenchymal fibroelastosis.
Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(2):212-217. doi: 10.36141/svdld.v37i2.9981. Epub 2020 Jun 30.
7
Lymphatic Function in Autoimmune Diseases.
Front Immunol. 2019 Mar 20;10:519. doi: 10.3389/fimmu.2019.00519. eCollection 2019.
8
Impact of mediastinal lymph node enlargement on the prognosis of idiopathic pulmonary fibrosis.
PLoS One. 2018 Jul 25;13(7):e0201154. doi: 10.1371/journal.pone.0201154. eCollection 2018.
9
Radiation-induced impairment in lung lymphatic vasculature.
Lymphat Res Biol. 2014 Dec;12(4):238-50. doi: 10.1089/lrb.2014.0012.
10
Inflammation-associated lymphangiogenesis: a double-edged sword?
J Clin Invest. 2014 Mar;124(3):936-42. doi: 10.1172/JCI71607. Epub 2014 Mar 3.

本文引用的文献

2
Intralobular pulmonary lymphatic distribution in normal human lung using D2-40 antipodoplanin immunostaining.
J Histochem Cytochem. 2009 Jul;57(7):643-8. doi: 10.1369/jhc.2009.953067. Epub 2009 Mar 16.
3
Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms.
Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3958-63. doi: 10.1073/pnas.0813368106. Epub 2009 Feb 23.
4
Lymphatic vessels develop during tubulointerstitial fibrosis.
Kidney Int. 2009 Apr;75(8):828-38. doi: 10.1038/ki.2008.661. Epub 2009 Jan 14.
5
Characterization of lymphangiogenesis in various stages of idiopathic diffuse alveolar damage.
Hum Pathol. 2009 Apr;40(4):542-51. doi: 10.1016/j.humpath.2008.06.031. Epub 2009 Jan 3.
6
Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo.
Circulation. 2009 Jan 20;119(2):281-9. doi: 10.1161/CIRCULATIONAHA.108.793208. Epub 2008 Dec 31.
7
The lymphatic system in health and disease.
Lymphat Res Biol. 2008;6(3-4):109-22. doi: 10.1089/lrb.2008.1008.
8
TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair.
Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H2113-27. doi: 10.1152/ajpheart.00879.2008. Epub 2008 Oct 10.
9
Short telomeres are a risk factor for idiopathic pulmonary fibrosis.
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13051-6. doi: 10.1073/pnas.0804280105. Epub 2008 Aug 27.
10
Serum inter-alpha-trypsin inhibitor and matrix hyaluronan promote angiogenesis in fibrotic lung injury.
Am J Respir Crit Care Med. 2008 Nov 1;178(9):939-47. doi: 10.1164/rccm.200803-386OC. Epub 2008 Aug 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验